We are pleased to announce that the *Shanghai Archives of Psychiatry* has now been accepted for registration in PsycINFO, a database with 2.7 million records that provides systematic coverage of the psychological literature from the 1800s to the present.

This issue starts with a Commentary about the Special Article by Paul Bebbington in the last issue\[[@B1]\] which discussed a new model for conceptualizing psychosis based on findings in psychosocial epidemiology. Murray and colleagues\[[@B2]\] acknowledges the important contribution that Bebbington's integration of cognitive theory and community-based epidemiology of the social risk factors and non-psychotic symptoms associated with psychotic-like conditions makes to our understanding of schizophrenia and related disorders, but they believe that a more complex model that includes the exciting new findings in genetics and molecular biology\[[@B3]\] is needed to move the field forward. They use the findings of the sociodevelopmentalcognitive model to suggest an updated dopamine hypothesis, one in which dopamine dysfunction is a dynamic process that can be altered by social stressors like child abuse or by biological challenges like cannabis use.

The second Commentary by Button and Munafo\[[@B4]\] discusses the network meta-analysis of cognitive behavioral therapy (CBT) for generalized anxiety disorder by Zhu and colleagues\[[@B5]\] which reported the surprising finding that current meta-analyses of CBT in generalized anxiety disorder do not meet the rigorous requirements specified by the Cochran Collaboration GRADE criteria of study quality and, thus, cannot be considered robust findings. Button and Munafo suggest that inadequate placebo control and failure to blind participants, therapists, and evaluators in psychotherapy trials make it difficult to remove potential bias and, thus, seriously reduces the robustness of the casual inferences that can be drawn from such trials. They suggest some options for reducing these biases in psychotherapy studies -- including learning about the basic science of the underlying mechanism of action of CBT, using measures of bias to adjust outcomes, and having multi-arm studies that assess each component of the intervention. But it will never be possible for randomized controlled trials of psychotherapeutic interventions to fully meet the robust GRADE criteria.

The systematic review and meta-analysis in this issue by Jiang and colleagues\[[@B6]\] considers randomized controlled trials about the effectiveness of metacognitive training (MCT) for schizophrenia, an exciting new adjunctive treatment for schizophrenia aimed at reducing positive symptoms, particularly delusions, by training patients to identify and alter the cognitive biases that underlie delusions and other psychotic symptoms.\[[@B7]\] They identified a total of 10 randomized controlled trials (RCTs), but these studies used different measures to assess outcomes so it was only possible to pool results for four studies that reported the positive symptom scale score of the Positive and Negative Syndrome Scale (PANSS) at the end of the intervention and for four studies that reported the delusion subscale score of the Psychotic Symptom Rating Scales (PSYRATS) at the end of the intervention. Overall, the results about the effectiveness of MCT were inconclusive; more randomized controlled trials that use standardized methods of assessing outcomes will be needed before deciding on whether or not to recommend MCT as a standard adjunctive treatment for schizophrenia.

The first Original Article by Chen and colleagues\[[@B8]\] adds to the growing literature about the 'brain network disconnection model' of schizophrenia,\[[@B9]\] which posits that abnormalities in the connectional architecture of the inter- and intra-hemispheric networks of the brain are responsible for the behavioral and cognitive abnormalities seen in schizophrenia. The study compared diffusion tensor imaging data from 24 male patients with paranoid schizophrenia during an acute phase of their illness with that of 24 healthy agematched male controls. Based on the constructed structural networks, they found longer mean characteristics path lengths (CPLs) in the patient group than in the control group for all 18 inter- and intrahemispheric networks assessed, though only some of the results were statistically significant. These findings support the 'connectivity hypothesis' of schizophrenia, but larger studies with more broadly representative samples of patients are needed to confirm the results.

The second Original Article by Zhou and colleagues\[[@B10]\] reports on a one-year follow-up of a controlled trial of community rehabilitation for patients with chronic schizophrenia provided at six community centers in one of the districts of Shanghai. The intervention, provided to 60 volunteers, included daycare five days a week, medication monitoring, recreational activities, and biweekly training about topics related to social and occupational functioning. Compared to 60 control subjects receiving treatment as usual (typically outpatient psychiatric visits every three months) the intervention group showed a greater improvement over the one-year follow-up on several standardized measures of attitude about treatment, social functioning, quality of life, and psychiatric symptoms. Thus, the intervention works, but it is unclear which component or components of the intervention were effective. Moreover, substantial time from professional staff are needed to implement the intervention so costeffective analysis and feasibility analysis are needed before trying to up-scale the intervention.

The third Original Article by Chen and colleagues\[[@B11]\] about the family environment of homeless individuals with schizophrenia in Xiangtan, Hunan administered the Chinese version of the self-completion Family Environment Scale\[[@B12]\] to 1856 homeless individuals (defined as living on the streets, public places, cars, deserted buildings, and so forth, for at least 7 days prior to admission) admitted to a psychiatric hospital with a diagnosis of schizophrenia and compared the results to that of 1728 non-homeless inpatients with schizophrenia. After controlling for demographic differences between the groups, homelessness was associated with several characteristics of the patients' reports of the functioning of their families. Homelessness among persons with mental illnesses is less common in China than in high-income countries, but a variety of social changes -- including rapid urbanization, the one-child per family policy, and the increased difficulty of admitting an ill family member because the new mental health law requires that most admissions be voluntary\[[@B13]\] -- are resulting in increasing numbers of homeless mentally ill. Identifying patients at high-risk of homelessness and the types of families they come from is an important first step to developing interventions to reduce the numbers of mentally individuals who become homeless.

The case report by Saha and Jakhar\[[@B14]\] discusses a rare case from India in which a brain tumor (an oligodendroglioma) presented with a three-year history of chronic mania. The late onset of the condition (at 52 years of age); its progressive, non-remitting course; and its non-responsiveness to standard medication eventually precipitated a MRI exam that identified the tumor. Surgical removal resulted in full resolution of the manic symptoms with some mild residual cognitive deficits. In many low- and middle-income countries brain imaging studies are often either not available or very expensive, so clinicians need to use clinical acumen to identify the characteristics that distinguish organic versus function etiology of psychiatric symptoms.

The Research Methods paper by Fan and colleagues\[[@B15]\] discusses the development of an instrument for assessing the severity of acute and chronic symptoms of ketamine abuse, an increasingly popular drug of abuse in China. They administered a preliminary 35-item checklist to 187 inpatients with ketamine dependence and used exploratory and confirmatory factor analysis of the results to generate a final 22-item scale that considered 4 groups of symptoms: social withdrawal, sleep disturbances, psychotic-like symptoms, and euphoria. Further work is needed to determine whether or not this new scale will be useful in monitoring the treatment of individuals with ketamine abuse or dependence.

The Biostatistics article by Chen\[[@B16]\] discusses an increasingly important component of research -- metaanalysis. The volume of psychiatric research available has increased dramatically over the last couple of decades so pooling prior results of previous studies is an essential prelude to any new study. If conducted well, meta-analysis can indicate what works, what doesn't work, and -- most importantly -- where additional research is needed. The article provides a brief overview of the fixed-effects and random-effects models of metaanalysis and provides an example of how to conduct these analyses using the open-access software package 'R' based on a previously published dataset.

Finally, we sadly report the passing of one of our distinguished international board members. Professor Wayne Katon, from the University of Washington in Seattle, was one of the most prominent advocates for bringing psychiatric practice into general medicine. As the editor-in-chief of General Hospital Psychiatry for several decades he championed the training of general physicians in the assessment and management of mental disorders and spearheaded their role in the provision of community-based mental health services. His influence is evident in general practice clinics around the United States and elsewhere where mental health services are now considered an integral part of the package of clinical services, something that was not the case three decades ago. Professor Katon was also a friend of the *Shanghai Archives of Psychiatry*, providing important intellectual support in our effort to create a bridge between psychiatric practice in China and elsewhere. He will be sorely missed by his colleagues, his students, and his patients.
